Cardiovascular medicine sales in Austria are forecasted to display a declining trend over the next five years, with the value decreasing from 2024 to 2028. In 2024, the value is predicted to be 45.3 US Dollars Per Capita, which is a continuation of the figures from the prior year 2023. Over the subsequent years, this value is expected to decline gradually, reaching 42.8 US Dollars Per Capita by 2028. The average year-on-year decrease from 2024 to 2028 is approximately 1.4%, with a cumulative average growth rate (CAGR) over the five-year period reflecting a consistent negative trend.
Future trends to watch for include changes in healthcare policies, advancements in cardiovascular treatments, demographic shifts, and potential economic fluctuations. These factors may influence the demand and sales of cardiovascular medicines, either mitigating or exacerbating the forecasted decline.
